FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 334:897-903 April 4, 1996 Number 14 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Autoimmune hepatitis is a chronic necroinflammatory liver disorder of unknown cause associated with circulating autoantibodies and a high serum globulin level. Since the first descriptions of the disorder in the 1950s, it has been known by a variety of terms, most commonly "autoimmune chronic active hepatitis," but in 1992 the International Autoimmune Hepatitis Group recommended the term "autoimmune hepatitis" as the most appropriate and least redundant for this disease.¹ It is important to distinguish autoimmune hepatitis from other forms of liver disease because a high percentage of cases respond to antiinflammatory and immunosuppressive treatment. Early diagnosis with appropriate management can . . . [Full Text of this Article]

Pathological Features

Pathogenesis

Clinical Features and Diagnosis

Treatment

Source Information

From the Gastroenterology Unit, University of Vermont College of Medicine, Burlington.

Address reprint requests to Dr. Krawitt at C-317 Given Bldg., University of Vermont College of Medicine, Burlington, VT 05405-0068.

References

Related Letters:

Evagination of Taenia solium in the Fourth Ventricle
Flisser A., Madrazo I.
Extract | Full Text  
N Engl J Med 1996; 335:753-754, Sep 5, 1996. Correspondence

This article has been cited by other articles:

• Hofer, H, Oesterreicher, C, Wrba, F, Ferenci, P, Penner, E (2006). Centrilobular necrosis in autoimmune hepatitis: a histological feature associated with acute clinical presentation.. J. Clin. Pathol. 59: 246-249 [Abstract] [Full Text]  
• Bilaj, F., Hyslop, W. B., Rivero, H., Firat, Z., Vaidean, G., Shrestha, R., Woosley, J. T., Semelka, R. C. (2005). MR Imaging Findings in Autoimmune Hepatitis: Correlation with Clinical Staging. Radiology 236: 896-902 [Abstract] [Full Text]  
• Giannini, E. G., Testa, R., Savarino, V. (2005). Liver enzyme alteration: a guide for clinicians. CMAJ 172: 367-379 [Abstract] [Full Text]  
• Rudner, L. A., Lin, J. T., Park, I.-K., Cates, J. M. M., Dyer, D. A., Franz, D. M., French, M. A., Duncan, E. M., White, H. D., Gorham, J. D. (2003). Necroinflammatory Liver Disease in BALB/c Background, TGF-{beta}1-Deficient Mice Requires CD4+ T Cells. J. Immunol. 170: 4785-4792 [Abstract] [Full Text]  
• Schramm, C., Protschka, M., Kohler, H. H., Podlech, J., Reddehase, M. J., Schirmacher, P., Galle, P. R., Lohse, A. W., Blessing, M. (2003). Impairment of TGF-beta signaling in T cells increases susceptibility to experimental autoimmune hepatitis in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 284: G525-G535 [Abstract] [Full Text]  
• MALIK, R., HODGSON, H. (2002). The relationship between the thyroid gland and the liver. QJM 95: 559-569 [Abstract] [Full Text]  
• (2002). Index of Suspicion. Pediatr. Rev. 23: 283-292 [Full Text]  
• Yoshida, E. M., Rasmussen, S. L., Steinbrecher, U. P., Erb, S. R., Scudamore, C. H., Chung, S. W., Oger, J. J., Hashimoto, S. A. (2001). Fulminant liver failure during interferon beta treatment of multiple sclerosis. Neurology 56: 1416-1416 [Full Text]  
• Pratt, D. S., Kaplan, M. M. (2000). Evaluation of Abnormal Liver-Enzyme Results in Asymptomatic Patients. NEJM 342: 1266-1271 [Full Text]  
• Kimura, M., Tatsumi, K.-I., Tada, H., Ikemoto, M., Fukuda, Y., Kaneko, A., Kato, M., Hidaka, Y., Amino, N. (2000). Enzyme Immunoassay for Autoantibodies to Human Liver-Type Arginase and Its Clinical Application. Clin. Chem. 46: 112-117 [Abstract] [Full Text]  
• Muratori, L, Cataleta, M, Muratori, P, Lenzi, M, Bianchi, F B (1998). Liver/kidney microsomal antibody type 1 and liver cytosol antibody type 1 concentrations in type 2 autoimmune hepatitis. Gut 42: 721-726 [Abstract] [Full Text]  
• Rich, J. D. (1996). Autoimmune Hepatitis. NEJM 335: 753-753 [Full Text]